Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion
Novartis AG will license a messenger RNA-based autoimmune therapy from Chinaโs Abogen Biosciences, in a deal worth as much as $7.8 billion.
This websiteโs original language is English. For translation, click the globe icon or choose Translate in the menu.
5 matching records found
Novartis AG will license a messenger RNA-based autoimmune therapy from Chinaโs Abogen Biosciences, in a deal worth as much as $7.8 billion.
The impact AI will have on entertainment, the next phase of the streaming wars and the deals reshaping the industry. Lucas Shaw shares the biggest moments you need to know about from the Bloomberg Screentime event in Los Angeles. Original filename: 10.1.26_Screentime_Wrap_1.mp4 (Source: Bloomberg)
The value of announced deals in the three months through September dipped roughly 10% year-on-year, according to data compiled by Bloomberg. Michelle Davis reports on "Bloomberg The Open." (Source: Bloomberg)
Indiaโs initial public offering market is heading toward a third consecutive blockbuster year, with a packed pipeline to build on its third-quarter momentum, punctuated by blockbuster deals.
A weekly, midday program that delivers high-impact, editorially driven coverage of the most important corporate transactions shaping the global market. Today's guests: Charlie Bouckaert - JPMorgan Global Head of M&A, and Michael Aiello - Weil, Gotshal & Manges Partner. (Source: Bloomberg)